Veracyte, Inc. announced that six abstracts highlighting new data from studies evaluating the company’s Decipher Prostate Genomic Classifier and related capabilities will be presented, three as.
The virtual meeting was held on April 23-25, 2021, where J&J featured a total of 13 posters and three oral presentations, including:
Presentation #26630: The Role of Skin Barrier in Cutaneous Adverse Drug Reactions in Oncology Therapy and the Benefit of Topical Emollients;
Presentation #26634: Insights into the Mechanisms of EGFRi-induced Cutaneous Adverse Drug Reactions From Functional Phospho-proteomic and Transcriptomic Data; and
Presentation #27031: Sunscreens Designed and Validated by Consumers to be Invisible on All Skin Tones. Sun protection including sunscreen is vital for everyone to protect their skin from sun damage and help prevent skin cancer,” said Barbara Green, senior director of skin health translational science at J&J. “However, a common misconception is that Black and Brown communities do not benefit from sunscreen. We formulated products specifically to be invisible on the skin while feeling weightless and breathable. She added J&J was pleased to prese
Johnson & Johnson Consumer Health Reveals New Skin Health Research at American Academy of Dermatology VMX 2021
Sixteen Presentations Reinforce Johnson & Johnson Consumer Health s Deep Commitment to Science-Based Innovations for Skin Health
News provided by
Share this article
Share this article
SKILLMAN, N.J., April 23, 2021 /PRNewswire/ Johnson & Johnson Consumer Health will present new research including among the first of its kind study on restorative skincare for cancer patients, new advances in multicultural skincare, the emotional impact of acne, and more to the world s leading dermatologists at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) April 23-25, 2021. A total of 16 posters will be presented at this year s conference, including three oral presentations.